[Physiopathology and therapy of systemic lupus erythematosus].
Kashiwagi
H
H
D000203:Activities of Daily Living; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000974:Antibodies, Antinuclear; D016736:Antiphospholipid Syndrome; D004334:Drug Administration Schedule; D000949:Histocompatibility Antigens Class II / Q000235:genetics; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy*; D008181:Lupus Nephritis / Q000150:complications; D012720:Severity of Illness Index; D013256:Steroids
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000974:Antibodies, Antinuclear; D000949:Histocompatibility Antigens Class II; D007166:Immunosuppressive Agents; D013256:Steroids